Recurrent Mycosis Fungoides Recruiting Phase 1 Trials for Daratumumab (DB09331)

Also known as: Mycosis fungoides recurrent

IndicationStatusPhase
DBCOND0080283 (Recurrent Mycosis Fungoides)Recruiting1
clinicaltrials.gov IdentifierTitlePurposeDrugs